Noncanonical (Non-R132H) IDH-Mutated Gliomas
Mutations in IDH1 or IDH2 confer a significant survival advantage compared to their isocitrate dehydrogenase (IDH) wild-type counterparts and, as such, are the most significant prognostic factors in this group. The mutations in the IDH1 gene are heterozygous and almost always involve only a single r...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/82321 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Noncanonical (Non-R132H) IDH-Mutated Gliomas
- The Distribution and Significance of IDH Mutations in Gliomas
- The Distribution and Significance of <em>IDH</em> Mutations in Gliomas
- Multimodal Oncology Agent for IDH1 Mutation Prediction in Low-Grade Glioma
- Computational Imaging Meets LLMs: Zero-Shot IDH Mutation Prediction in Brain Gliomas
- The Role of Isocitrate Dehydrogenase Mutations in Glioma Brain Tumors
- Canonical and Noncanonical Hamiltonian Operator Inference